Molecular diagnosis of human prion disease.
Human prion diseases are associated with a range of clinical presentations, and they are classified by both clinicopathological syndrome and etiology, with subclassification according to molecular criteria. Here, we describe procedures that are used within the MRC Prion Unit to determine a molecular diagnosis of human prion disease. Sequencing of the PRNP open reading frame to establish the presence of pathogenic mutations is described, together with detailed methods for immunoblot or immunohistochemical determination of the presence of abnormal prion protein in brain or peripheral tissues.
Wadsworth
Jonathan D F
JD
MRC Prion Unit, University College London Institute of Neurology, London, UK.
Powell
Caroline
C
Beck
Jonathan A
JA
Joiner
Susan
S
Linehan
Jacqueline M
JM
Brandner
Sebastian
S
Mead
Simon
S
Collinge
John
J
D001483:Base Sequence; D006801:Humans; D015151:Immunoblotting; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D014066:Palatine Tonsil / Q000473:pathology; D018621:PrPC Proteins / Q000235:genetics; D017096:Prion Diseases / Q000175:diagnosis* / Q000378:metabolism* / Q000473:pathology
D018621:PrPC Proteins